About DMCN

Developmental Medicine & Child Neurology (DMCN) is owned by Mac Keith Press. It is of interest to researchers, all health professionals concerned with developmental disability and child neurology, and others involved in the care of disabled children and young people.

Scope

The breadth of subjects covered by DMCN include:

  • Paediatric Neurology
  • Neurodisability
  • Child and Adolescent Psychiatry
  • Orthopaedics and Neurosurgery
  • Neurogenetics
  • Neurophysiology
  • Neuropathology
  • Child Psychology
  • Physical, Occupational and Speech/Language Therapies
  • Orthotics and Assistive Technologies
  • Neuroimaging

Special features

Special features of the journal include Podcasts, Editor’s Choice, and Virtual Issues. Click here to see more.

Editorial Board

Members of the Editorial Board are selected based on their expertise, and are vital to ensure the high quality of the publications.

Peer Review

The first stage of our review process is an editorial discussion about the paper’s suitability for the journal by our Editorial Board. This may lead to the decision to not accept the paper, or to send it for the second stage: review by at least two independent referees. During the submission process, authors have the opportunity to suggest up to three suitable referees, with contact details, although the choice of referee remains with the Editors.

At a late stage in the review process, papers with statistical analyses undergo specific statistical review. The Editors recommend ‘Statistical recommendations for papers submitted to Developmental Medicine & Child Neurology’ (here) for guidelines on appropriate use and reporting of statistical analyses.

Editors and editorial board members are not involved in editorial processes or decisions about their own work. Reviewers are asked to disclose potential conflicts of interest when they are invited to review a paper and when they submit their review. DMCN is a member of the Committee on Publication Ethics (COPE).

Submission

Please read our Author Guidelines before submitting your paper.

Please visit the online submission site to submit your paper.

There are many advantages to submitting your paper to DMCN:

  • Fast time to first decision
  • Fast publication times
  • High visibility – all articles published are free to access 12 months after publication
  • Better paper tracking – from submission through to acceptance and publication using Author Services
  • High impact factor and wide readership
  • Statistical reviews of original articles before final acceptance
  • REF compliant

Latest journal metrics:

2-Year Impact Factor: 5.449
5-Year Impact Factor: 5.366

Submission to first decision: 23 days
Acceptance to online publication: 41 days
Acceptance rate: 19%

Access

For information regarding subscriptions (both online and print), please visit the Wiley site. All articles published in DMCN are free to access 12 months after publication. Authors who wish to make their papers freely accessible immediately upon publication may use Wiley’s pay-to-publish service, Open Access. You can access the journal’s content here.

Data sharing and accessibility

DMCN expects data sharing and recognizes the many benefits of archiving research data. DMCN expects you to archive all the data from which your published results are derived in a public repository.

All accepted manuscripts are required to publish a data availability statement to confirm the presence or absence of shared data. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier from the repository where you shared the data.

See the Data sharing section in the author guidelines for further details.

Member discount

DMCN is the Official Journal of several organisations and special discounts are offered to members.